Increased activation of this pathway, observed in our study through elevated AKT1 and BRCA1 expression, can lead to enhanced tumor cell survival and resistance to apoptosis (Foster et al., 2009; Wang et al., 2016). This evidence concerns the gene AKT1 and neoplasm.